Home > Boards > US Listed > Biotechs > Rexahn Pharmaceuticals, Inc. (RNN)

Rexahn Announces Presentation of RX-3117 Data at the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
pennytrader33 Member Profile
 
Followed By 9
Posts 255
Boards Moderated 0
Alias Born 10/04/08
160x600 placeholder
Certification by the Exchange Approving Securities for Listing (cert) Edgar (US Regulatory) - 6/10/2019 9:32:00 AM
Securities Registration (section 12(b)) (8-a12b) Edgar (US Regulatory) - 6/7/2019 4:56:42 PM
Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme... Edgar (US Regulatory) - 6/7/2019 4:41:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:22:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:22:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:19:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:17:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:14:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:13:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 2:20:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2019 12:58:09 PM
Rexahn Announces Move to Nasdaq GlobeNewswire Inc. - 5/28/2019 4:10:00 PM
Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/13/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 4:22:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2019 4:45:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2019 8:04:12 AM
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China GlobeNewswire Inc. - 4/16/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2019 8:16:52 AM
Rexahn Effects 1-for-12 Reverse Stock Split GlobeNewswire Inc. - 4/12/2019 8:00:00 AM
Rexahn Announces Reverse Stock Split GlobeNewswire Inc. - 4/10/2019 4:07:00 PM
Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual Meeting GlobeNewswire Inc. - 3/27/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2019 4:15:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/11/2019 6:55:34 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/11/2019 6:32:33 AM
Rexahn Pharmaceuticals Reports 2018 Financial Results GlobeNewswire Inc. - 3/8/2019 8:00:00 AM
pennytrader33   Monday, 01/14/19 03:28:59 PM
Re: None
Post # of 3880 
Rexahn Announces Presentation of RX-3117 Data at the 2019 ASCO Gastrointestinal Cancers Symposium

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist